Skip to content

How Phenotypical Characteristics of Woebot Users Are Related to Clinical Outcomes

An Open-label Pilot Study to Learn How the Phenotypical Characteristics of Woebot Users Are Related to Clinical Outcomes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05672745
Enrollment
256
Registered
2023-01-05
Start date
2022-05-11
Completion date
2022-07-23
Last updated
2023-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To Understand the Characteristics of Digital Mental Health Intervention Users as They Relate to Mental Health Outcomes

Brief summary

The goal of this observational study is to understand the characteristics of Woebot users as they relate to clinical outcomes. The objectives it aims to address are: 1. To assess Woebot usage patterns, satisfaction ratings, self-efficacy, stress, resilience, work productivity and activity impairment, alexthymia, and bond over time based on demographic, clinical baseline levels, and attitudinal characteristics 2. Among users who present with clinical levels of anxiety or depression, to assess the contribution of demographic characteristics, attitudinal characteristics, and patterns of engagement on clinical outcomes of interest over time 3. To collect and explore attitudinal characteristics of Woebot users regarding their experiences with mental health care and perceived value of digital tools for emotional support 4. Explore meaningful subgroups of Woebot users based on demographic and attitudinal characteristics, clinical outcomes, and patterns of engagement Participants who meet study eligibility requirements will be: * invited to engage with the Woebot Life program for 8 weeks * complete survey assessments at day 3, week 4 (mid-intervention), and week 8 (end of intervention)

Interventions

DEVICEWB-LIFE

WB-LIFE is a mobile application program grounded in validated psychotherapies (including cognitive behavioral therapy, interpersonal, and dialectical behavioral therapy), that enlists the relational agent Woebot to guide users in managing their mood. The user experience is driven by artificial intelligence and centers around mood tracking, evidence-based tools, and goal-oriented, tailored conversations.

Sponsors

Woebot Health
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18+ years old * US resident * English literacy * Availability to complete survey assessments * Ownership or regular access to a smartphone with WiFi and sufficient data access for the duration of the study.

Exclusion criteria

* Current suicidal ideation with a plan or intent or a suicide attempt within the past 12 months * A reported lifetime diagnosis of a psychotic disorder (including schizophrenia or schizoaffective disorder) or bipolar disorder * Previous use of the Woebot application

Design outcomes

Primary

MeasureTime frameDescription
BurnoutChange from Baseline to Mid-Intervention at Week 4; change from Baseline to Post-intervention at Week 8; change from Mid-Intervention at Week 4 to Post-intervention at Week 8Single-item question to measure burnout on a scale from 1-5, where 5 is feeling completely burned out to the point change is needed.
Brief Resilience Questionnaire (BRS)Change from Baseline to Mid-Intervention at Week 4; change from Baseline to Post-intervention at Week 8; change from Mid-Intervention at Week 4 to Post-intervention at Week 8The BRS is a measure used to assess a person's ability to bounce back or recover after experiencing a stressor. Total scores range from 1 (low resilience) to 5 (high resilience).
Perceived Stress Scale (PSS)Change from Baseline to Mid-Intervention at Week 4; change from Baseline to Post-intervention at Week 8; change from Mid-Intervention at Week 4 to Post-intervention at Week 8The PSS is a 10-item tool to assess individual levels of stress in the past month. Total scores range from 0 (no stress) to 40 (very high levels of stress).
Toronto Alexithymia Scale (TAS)Change from Baseline to Mid-Intervention at Week 4; change from Baseline to Post-intervention at Week 8; change from Mid-Intervention at Week 4 to Post-intervention at Week 8The TAS-20 is an instrument that measures alexithymia, or difficulty with identifying and describing emotions and focusing attention externally. Total scores range from 20-100, with with low levels of alexithymia indicative of high levels of emotional self-awareness and vice versa.
App engagement metricsBaseline to Post-intervention at Week 8Data tracking mobile application use, including conversational interactions with Woebot and patterns of engagement over time, will be collected throughout the duration of treatment (8-weeks).
Client Satisfaction Questionnaire (CSQ-8)Post-intervention at Week 8An 8-item measure used to assess client's satisfaction with treatment.Total scores range from 8-32, with high scores indicating greater satisfaction with the treatment.
Working Alliance Inventory (WAI)Change from Day 3 to Mid-Intervention at Week 4; change from Day 3 to Post-intervention at Week 8; change from Mid-Intervention at Week 4 to Post-intervention at Week 8Measure of working alliance. A measure of therapeutic alliance that assesses three key aspects of the therapeutic alliance: (a) agreement on the tasks of therapy, (b) agreement on the goals of therapy and (c) development of an affective bond. Total scores range from 12-60, with higher scores indicating greater alliance. The present study utilized the validated 12-item Short-Revised version (WAI-SR) with minor changes to language, replacing therapist with Woebot.
Mental Health Self-Efficacy Scale (MHSES)Change from Baseline to Mid-Intervention at Week 4; change from Baseline to Post-intervention at Week 8; change from Mid-Intervention at Week 4 to Post-intervention at Week 8Six items assess confidence in managing stress, depression, and anxiety, and are scored on a 10 point Likert scale (from 1, not at all confident to 10, very confident). Ratings across the 6 items are summed for an overall measure of MHSES (range 10 to 60), with higher scores indicating more self-efficacy. This measure is included as a way to capture an individual's confidence that they can successfully manage their mental health concerns.
Work Productivity and Activity Impairment (WPAI)Change from Baseline to Mid-Intervention at Week 4; change from Baseline to Post-intervention at Week 8; change from Mid-Intervention at Week 4 to Post-intervention at Week 8The WPAI measures presenteeism, absenteeism, work productivity loss for the currently employed, and activity impairment. WPAI outcomes are expressed as impairment percentages, with higher numbers indicating greater impairment and less productivity
Patient-Reported Outcomes Measurement Information System Global Health (PROMIS)Change from Baseline to Mid-Intervention at Week 4; change from Baseline to Post-intervention at Week 8; change from Mid-Intervention at Week 4 to Post-intervention at Week 8Ten items used to assess five core domains of health (physical function, pain, fatigue, emotional distress, and social). Total scores range from 5-50, where greater scores represent the best health and functioning.
Patient Health QuestionnaireChange from Baseline to Mid-Intervention at Week 4; change from Baseline to Post-intervention at Week 8; change from Mid-Intervention at Week 4 to Post-intervention at Week 8Measure of depression. An 8-item self-report questionnaire where total scores range from 0 to 24, with higher scores indicating greater levels of depression
Generalized Anxiety Disorder QuestionnaireChange from Baseline to Mid-Intervention at Week 4; change from Baseline to Post-intervention at Week 8; change from Mid-Intervention at Week 4 to Post-intervention at Week 8Measure of anxiety. A 7-item brief self-report questionnaire, where total score range is between 0-21, with higher scores indicate greater levels of anxiety.

Secondary

MeasureTime frameDescription
Woebot Attitudinal Survey (WAS)Post-intervention at Week 8The 9-item survey was designed to assess the user's perceptions of their Woebot experience - perceptions of skills learned, emotional challenges addressed, relational quality (comprehension of information, relevance of suggestions offered, perceptions of support, lack of judgment), applications of Woebot suggestions in daily life, and perceptions about the session duration and length of engagement with Woebot app needed for Woebot to work effectively.
Perceived Barriers to Care (PBC)Day 3 of InterventionThe PBC is a 30-item assesses perceived barriers to access mental health care on a scale of 1= not at all to 5 = impossible, including Stigma, Lack of motivation, Emotional concerns, Negative evaluations of therapy, Misfit of therapy to needs, Time constraints, Participation restriction, Availability of Services, and Cost.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026